Participants were seen monthly for the first
3 months and every 3 months thereafter. Medications
for participants in the intensive-treatment
group were adjusted on a monthly basis
to target a systolic blood pressure of less than
120 mm Hg. For participants in the standardtreatment
group, medications were adjusted
to target a systolic blood pressure of 135 to
139 mm Hg, and the dose was reduced if systolic
blood pressure was less than 130 mm Hg
on a single visit or less than 135 mm Hg on two
consecutive visits.